California State Teachers Retirement System (CalSTRS)’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADCT
NCM
RG
TCM
PM
California State Teachers Retirement System (CalSTRS)'s ADCT Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its ADC Therapeutics (ADCT) stake by 74% in Q2 2026, selling an estimated $12.1K and leaving 1,431 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2944.
California State Teachers Retirement System (CalSTRS) first reported a position in ADCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $24K in Q3 2025. 113 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 1,431 shares of ADC Therapeutics worth $1.53K as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 4,142 ADC Therapeutics shares in Q2 2026, an estimated $12.1K.
- ADC Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2944 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in ADC Therapeutics in Q2 2024 and has held it in 9 quarters since.
- California State Teachers Retirement System (CalSTRS)'s ADC Therapeutics position peaked at $24K in Q3 2025.
- 113 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.